Results 91 to 100 of about 47,001 (202)

Factors Associated With Professional Fulfillment, Work Exhaustion, and Job Turnover Intention Among Infectious Diseases Pharmacists

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 10, October 2026.
ABSTRACT Background Infectious diseases (ID) pharmacists practice in an important therapeutic area and hold critical roles including leading antimicrobial stewardship (AMS) programs and participating in ID clinical services. High United States pharmacist burnout prevalence, before and after the coronavirus disease 2019 (COVID‐19) pandemic, ensures ...
David A. Mott, Aaron M. Gilson, Samuel L. Aitken, Melissa Johnson, Erin K. McCreary, Elizabeth B. Hirsch   +5 more
wiley   +1 more source

Feasibility Investigation on the Effects of a 6‐Week Whole‐Body Static Stretching Program in Active Adults With Type 1 Diabetes on Blood Glucose and Insulin Sensitivity

Lifestyle Medicine, Volume 7, Issue 4, October 2026.
ABSTRACT Background Exercise is a cornerstone non‐pharmacological strategy for glucose management in people with Type 1 diabetes (T1D). However, barriers such as fear of hypoglycemia and time constraints may limit participation in conventional exercise programs. Static stretching (SS) represents a low‐intensity, accessible modality that requires little
Salvatore Frenda, Masatoshi Nakamura, Konstantin Warneke, Salvatore Ficarra, Antonino Bianco, Ewan Thomas   +5 more
wiley   +1 more source

Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma

Nature Communications
Next Generation Sequencing-based subtyping and interim- and end of treatment positron emission tomography (i/eot-PET) monitoring have high potential for upfront and on-treatment risk assessment of diffuse large B-cell lymphoma patients. We performed Dana
Matías S. Mendeville, Jurriaan Janssen, G. Tjitske Los-de Vries, Erik van Dijk, Julia Richter, Marcel Nijland, Margaretha G. M. Roemer, Phylicia Stathi, Nathalie J. Hijmering, Reno Bladergroen, Diego A. Pelaz, Arjan Diepstra, Corinne J. Eertink, Coreline N. Burggraaff, Yongsoo Kim, Pieternella J. Lugtenburg, Anke van den Berg, Alexandar Tzankov, Stefan Dirnhofer, Ulrich Dührsen, Andreas Hüttmann, Wolfram Klapper, Josée M. Zijlstra, Bauke Ylstra, Daphne de Jong   +24 more
doaj   +1 more source

Optimal, Interpretable, and Personalized Immune Checkpoint Inhibitor Duration in Non‐Small Cell Lung Cancer: A Multicenter Real‐World Study

MedComm, Volume 7, Issue 10, October 2026.
This multicenter retrospective study of 1054 patients with NSCLC developed an interpretable Optimal Policy Survival Tree using a counterfactual random forest reward‐estimation matrix based on age, tumor diameter, and dNLR. The model identified seven patient subgroups with distinct phenotype‐associated treatment‐duration patterns: 37.8% showed more ...
Siqi Wang, Jianhua Liu, Qiang Nie, Ruichuan Shi, Nan Xu, Qianqian He, Guanchao Ye, Jingyi Liu, Qiuyang Hou, Kexue Deng, Lu Wang, Taixue An, Anyi An, Xiujuan Qu, Jiangdian Song   +14 more
wiley   +1 more source

Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer

ImmunoTargets and Therapy
Chiara Corti,1– 4 Beyza Koca,1,2 Tasnim Rahman,1,2 Elizabeth A Mittendorf,1,2,5 Sara M Tolaney1,2,6 1Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; 2Harvard Medical School, Boston, MA, USA; 3Division of New Drugs and Early ...
Corti C, Koca B, Rahman T, Mittendorf EA, Tolaney SM   +4 more
doaj  

Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial

British Journal of Haematology, Volume 209, Issue 4, Page 1818-1827, October 2026.
Summary Avatrombopag treatment resulted in significantly higher platelet response rates in patients when compared with placebo in a phase 3b study of patients with paediatric immune thrombocytopenia (ITP) (NCT04516967). These post hoc analyses of the 12‐week core phase further assessed the efficacy of avatrombopag, considering the influence of baseline
Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Sule Unal, John Grainger, Amanda B. Grimes, Michele P. Lambert, Jessica Zhang, Brian D. Jamieson, Faizan Sattar, Scott Kolodny, Michael Vredenburg, on behalf of the AVA‐PED‐301 Study Group   +12 more
wiley   +1 more source

Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review. [PDF]

JIMD Rep, 2019
Goudie C, Alayoubi AM, Tibout P, Duval M, Maranda B, Mitchell D, Mitchell JJ.   +6 more
europepmc   +1 more source

The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study

BJU International, Volume 138, Issue 4, Page 600-606, October 2026.
Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng, Kara N. Maxwell, Keyan Salari, Matthew R. Cooperberg, Kristin Follmer, Joanne M. Jeter, Grace Jun, Daniel J. Lee, Hiten D. Patel, Edward M. Schaeffer, Alexandra O. Sokolova, Erika M. Wolff, Daniel W. Lin   +12 more
wiley   +1 more source

Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice. [PDF]

BBA Clin, 2017
He X, Dworski S, Zhu C, DeAngelis V, Solyom A, Medin JA, Simonaro CM, Schuchman EH.   +7 more
europepmc   +1 more source

Phase IIB, Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID‐19

European Journal of Haematology, Volume 117, Issue 4, Page 922-935, October 2026.
ABSTRACT Introduction Endothelial dysfunction is key in COVID‐19 pathogenesis. This randomized, double‐blind phase IIb trial investigated continuous intravenous infusion of defibrotide in patients hospitalized with SARS‐CoV‐2 infection and respiratory failure.
Ruben Jara Rubio, Antonio José Martinez‐Mellado, Jonathan Kiwitt‐Cárdenas, José G. Clavel, Bartolomé García‐Perez, Pedro Castro, Maribel Diaz‐Ricart, Andrés Carrillo‐Alcaraz, Amparo López‐Bernús, Enrique Bernal Morell, Aychel Roura, Sonia Marín, Francisco‐José Ruiz‐López, Elena Solana‐Martinez, Domingo Martinez‐Baño, Carlos L. Albacete Moreno, Enriqueta Andreu Soler, Adrián Tellez Santoyo, Sara Fernández Méndez, Jose A. Noguera Velasco, Iria Cebreiros Lopez, Andrés Parrilla, Alberto Espuny‐Miró, David García‐Bernal, Miguel Blanquer, Andrés Sánchez‐Salinas, Francisca Iniesta, Cristina Hernandez Garcia, Manuel Muro, Alfredo Minguela Puras, Antonio Moreno‐Docón, Alberto M. Torres‐Cantero, Maria Munoz Garcia, Manuel Serrano, Massimo Iacobelli, Carmelo Carlo‐Stella, Lee‐Jen Wei, Paul G. Richardson, José M. Moraleda   +38 more
wiley   +1 more source